Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05787899 · ClinicalTrials.gov registry record
Hypothermia's Effect on Hepatitis B Vaccination
A clinical trial, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- 9
- Enrollment target
NCT05787899 is a clinical trial that has completed, run by Medical University of South Carolina. The registered enrollment target is 9 participants.
The verdict
NCT05787899 has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- 9 participants
- Enrollment target
Study Summary
The purpose of the research is to determine if the Hepatitis B vaccine after birth provides enough protection after cooling for Hypoxic Ischemic Encephalopathy (HIE). To do this, Hepatitis B titers (blood sample) would be taken before, during, and after administering of the Hepatitis B vaccine series to measure efficacy of the vaccine.
Interventions
- OTHER Hypothermia Protocol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2023-05-18 |
| Est. Completion | 2024-10-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05787899
The ClinicalTrials.gov registry entry for NCT05787899 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Hypothermia Protocol is the first listed.
NCT05787899 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05787899 about?
NCT05787899 is a clinical study titled "Hypothermia's Effect on Hepatitis B Vaccination". The purpose of the research is to determine if the Hepatitis B vaccine after birth provides enough protection after cooling for Hypoxic Ischemic Encephalopathy (HIE). To do this, Hepatitis B titers (blood sample) would be taken before, during, and after administering of the Hepatitis B vaccine serie...
What is the current status of trial NCT05787899?
This trial is currently completed. The enrollment target is 9 participants. The study started on 2023-05-18. Estimated completion is 2024-10-01.
What interventions are being tested in trial NCT05787899?
The interventions under investigation include: Hypothermia Protocol (OTHER).
Who is sponsoring clinical trial NCT05787899?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.